Mirum Pharmaceuticals (MIRM) Other Operating Expenses (2021 - 2026)

Mirum Pharmaceuticals' Other Operating Expenses history runs 6 years deep, the most recent figure standing at $755.1 million for Q1 2026.

• On a quarterly basis, Other Operating Expenses rose 2595.08% year-over-year to $755.1 million in Q1 2026; TTM through Mar 2026 was $832.3 million, a 806.37% increase from a year earlier, with the FY2025 full-year figure at $100.2 million, up 22.78% from the prior year.
• Other Operating Expenses rose to $755.1 million in Q1 2026 per MIRM's latest filing, from $28.3 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $755.1 million in Q1 2026 and bottomed at $2.4 million in Q1 2022.
• The 5-year median for Other Operating Expenses is $20.2 million (2024), against an average of $58.9 million.
• Across the five-year window, Other Operating Expenses decreased 8.95% in 2024 and soared 2595.08% in 2026, its largest moves.
• Year by year, Other Operating Expenses stood at $4.5 million in 2022, then surged by 456.74% to $25.0 million in 2023, then fell by 8.95% to $22.8 million in 2024, then gained by 24.07% to $28.3 million in 2025, then jumped by 2571.62% to $755.1 million in 2026.
• Per Business Quant, the three latest MIRM Other Operating Expenses figures stand at $755.1 million (Q1 2026), $28.3 million (Q4 2025), and $25.5 million (Q3 2025).